Showing results (161-170 of 1,399) with videos related to

Sort By:
Pageof 140
Pharmacology Research & Perspectives|February 1, 2021
Elimination of macrophages reduces glutaraldehyde-fixed porcine heart valve degeneration in mice subdermal modelZongtao Liu, Yixuan Wang, Fei Xie, et al.
Pharmacology Research & Perspectives|December 17, 2021
Long-term benzodiazepines and z-drug prescribing in Australian general practice between 2011 and 2018: A national studyAmelia Woods, Mumtaz Begum, David Gonzalez-Chica, et al.
Pharmacology Research & Perspectives|December 28, 2021
M1 muscarinic receptor activation decreases alcohol consumption via a reduction in consummatory behaviorLeigh C Walker, Erin J Campbell, Kate L Huckstep, et al.
Pharmacology Research & Perspectives|December 30, 2021
Molnupiravir: A new candidate for COVID-19 treatmentFariba Pourkarim, Samira Pourtaghi-Anvarian, Haleh Rezaee
Pharmacology Research & Perspectives|September 14, 2022
What is the evidence that a pharmacy team working in an acute or emergency medicine department improves outcomes for patients: A systematic reviewEkta Punj, Abbie Collins, Nirlep Agravedi, et al.
Pharmacology Research & Perspectives|September 16, 2022
A small-group activity to enhance learning of cardiovascular drugs for health science studentsKatharina Brandl, Stephen Schneid, Nora Laiken
Pharmacology Research & Perspectives|October 7, 2022
Correlation between the drug concentration of polymyxin B and polymyxin B-associated acute kidney injury in critically ill patients: A prospective studyYing Xu, Pei Liang, Ning Liu, et al.
Pharmacology Research & Perspectives|September 9, 2022
Pharmacological hypothesis: A recombinant probiotic for taming bacterial β-glucuronidase in drug-induced enteropathyManon Jardou, Clarisse Brossier, Kenza Guiyedi, et al.
Pharmacology Research & Perspectives|September 6, 2022
Correlation of functional and radioligand binding characteristics of GPER ligands confirming aldosterone as a GPER agonistQingming Ding, Jozef Chorazyczewski, Robert Gros, et al.
Pharmacology Research & Perspectives|October 5, 2021
Immunomodulation induced by central nervous system-related peptides as a therapeutic strategy for neurodegenerative disordersMaría Laura Palumbo, Alejandro David Moroni, Sofía Quiroga, et al.
Pageof 140